Biostatistics Quiz: Relative Risk And Risk Difference
20 questions · exam conditions
0:00
Relative Risk And Risk DifferenceQuestion 1 of 20

A cohort study follows 1,200 smokers and 800 non-smokers for 10 years to assess lung cancer development. Among smokers, 48 develop lung cancer. Among non-smokers, 8 develop lung cancer. What is the relative risk of lung cancer for smokers compared to non-smokers?

4.0
6.0
2.4
5.0
3.2
← Back to quizzes

Biostatistics Quiz

Biostatistics Quiz: Relative Risk And Risk Difference

Practice Relative Risk And Risk Difference in Biostatistics with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Relative Risk And Risk Difference, giving you a quick way to practice the rules, question types, and explanations that matter most for Biostatistics.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A cohort study follows 1,200 smokers and 800 non-smokers for 10 years to assess lung cancer development. Among smokers, 48 develop lung cancer. Among non-smokers, 8 develop lung cancer. What is the relative risk of lung cancer for smokers compared to non-smokers?

  1. 4.0 (correct answer)
  2. 6.0
  3. 2.4
  4. 5.0
  5. 3.2
Explanation: When you encounter a cohort study asking about relative risk, you're calculating how many times more likely an exposed group is to develop an outcome compared to an unexposed group. The formula is: Relative Risk=Risk in exposed groupRisk in unexposed group\text{Relative Risk} = \frac{\text{Risk in exposed group}}{\text{Risk in unexposed group}} First, calculate the risk (incidence rate) in each group. For smokers: 48 lung cancers ÷ 1,200 smokers = 0.04 or 4%. For non-smokers: 8 lung cancers ÷ 800 non-smokers = 0.01 or 1%. Now apply the relative risk formula: RR=0.040.01=4.0\text{RR} = \frac{0.04}{0.01} = 4.0 This means smokers are 4 times more likely to develop lung cancer than non-smokers, making answer A correct. Let's examine why the other options are wrong. Answer B (6.0) might result from incorrectly dividing 48 by 8 (the raw number of cases), but this ignores the different population sizes. Answer C (2.4) could come from miscalculating the denominator, perhaps using the wrong population figures. Answer D (5.0) doesn't correspond to any logical calculation error but serves as a close distractor. Remember this pattern: relative risk questions always require you to first calculate the risk (cases ÷ population) in each group, then divide the exposed group's risk by the unexposed group's risk. Never work directly with raw case numbers—always convert to rates first, accounting for different group sizes.

Question 2

A case-control study cannot directly calculate relative risk, but can estimate it using the odds ratio when the disease is rare. If a cohort study of the same population found a relative risk of 3.2 for the association between exposure X and disease Y, and disease Y has a prevalence of 15% in the population, how well would the odds ratio approximate the relative risk?

  1. The odds ratio would substantially overestimate the relative risk due to high disease prevalence (correct answer)
  2. The odds ratio would closely approximate the relative risk since 15% prevalence is considered rare
  3. The odds ratio would underestimate the relative risk by approximately 50%
  4. The odds ratio would be exactly equal to the relative risk regardless of disease prevalence
  5. The odds ratio approximation cannot be evaluated without knowing the exposure prevalence
Explanation: When you encounter questions about odds ratios approximating relative risk, you need to understand that this approximation only works well when disease prevalence is genuinely rare (typically <10%). The relationship between odds ratio (OR) and relative risk (RR) depends critically on disease frequency. When disease prevalence is low, the odds ratio closely approximates the relative risk. However, as disease prevalence increases, the odds ratio increasingly overestimates the relative risk. At 15% prevalence, this overestimation becomes substantial. Here's why: the odds ratio compares odds rather than risks. With higher disease prevalence, the denominator in odds calculations (1 - probability) becomes notably smaller, inflating the odds ratio compared to the relative risk, which directly compares probabilities. Answer A correctly identifies that the odds ratio would substantially overestimate the relative risk due to the high (15%) disease prevalence. Answer B is incorrect because 15% prevalence is not considered rare in epidemiological terms - the "rare disease assumption" typically requires prevalence below 10%. Answer C incorrectly suggests underestimation when the odds ratio actually overestimates relative risk at higher prevalences. Answer D is completely wrong since the relationship between odds ratio and relative risk is never exact except in theoretical scenarios with zero disease prevalence. Study tip: Remember the "10% rule" - odds ratios only approximate relative risk well when disease prevalence is below 10%. Above this threshold, odds ratios progressively overestimate relative risk, making case-control studies less reliable for estimating true relative risk.

Question 3

In a study comparing two surgical procedures, Procedure A has a 3% complication rate and Procedure B has a 9% complication rate. If a hospital switches from Procedure B to Procedure A for all cases, what proportion of complications would be prevented?

  1. 67% of complications would be prevented (correct answer)
  2. 6 percentage points of complications would be prevented
  3. 33% of complications would be prevented
  4. 3 times fewer complications would occur
  5. 75% of complications would be prevented
Explanation: When you encounter questions about reducing disease rates or complications, you're dealing with relative risk reduction - a key concept in epidemiology that measures the proportional decrease in adverse outcomes. To find what proportion of complications would be prevented, you need to calculate how much the complication rate decreases relative to the original rate. Start with Procedure B's 9% rate and Procedure A's 3% rate. The absolute reduction is 9%−3%=6%9\% - 3\% = 6\%. However, the question asks for the proportion of complications prevented, which requires dividing this reduction by the original rate: 6%9%=0.67=67%\frac{6\%}{9\%} = 0.67 = 67\%. This means that switching procedures would prevent 67% of the complications that would have occurred under Procedure B. Option A correctly identifies this 67% relative risk reduction. Option B states "6 percentage points" - this describes the absolute risk reduction, not the proportion prevented. While mathematically correct, it doesn't answer what was asked. Option C gives 33%, which would be the remaining complication rate expressed as a fraction of the original rate (3%9%=33%\frac{3\%}{9\%} = 33\%), but this represents complications that still occur, not those prevented. Option D mentions "3 times fewer," which is imprecise language and doesn't properly quantify the proportional reduction. Remember: absolute risk reduction tells you the raw difference in rates, while relative risk reduction tells you the proportional improvement - always read carefully to determine which the question is asking for.

Question 4

In a clinical trial, Drug X shows a relative risk of 0.6 for preventing stroke compared to placebo. The trial included patients with a baseline stroke risk of 10% over 2 years. If 1,000 patients are treated with Drug X instead of placebo, what is the expected number of strokes prevented?

  1. 40 strokes prevented (correct answer)
  2. 60 strokes prevented
  3. 100 strokes prevented
  4. 25 strokes prevented
  5. 150 strokes prevented
Explanation: When you encounter questions about relative risk and stroke prevention, you need to convert the relative risk into actual prevented cases by calculating the absolute risk reduction. Here's how to work through this step-by-step: First, identify what happens without treatment - with a 10% baseline risk, 1,000 patients on placebo would experience 1000×0.10=1001000 \times 0.10 = 100 strokes over 2 years. Next, calculate what happens with treatment - a relative risk of 0.6 means Drug X patients have 60% of the original risk, so 1000×0.10×0.6=601000 \times 0.10 \times 0.6 = 60 strokes would occur. The difference gives you strokes prevented: 100−60=40100 - 60 = 40 strokes prevented. Let's examine why the other answers miss the mark. Answer B (60 strokes prevented) incorrectly uses the number of strokes that still occur with treatment rather than those prevented. Answer C (100 strokes prevented) assumes Drug X prevents all strokes, ignoring that the relative risk is 0.6, not 0. Answer D (25 strokes prevented) appears to misapply the relative risk calculation, possibly confusing it with a different risk reduction formula. The key insight is that relative risk tells you what fraction of the original risk remains, not what's prevented. Always calculate both the expected cases with and without treatment, then find the difference. Remember: prevented cases = baseline cases - treated cases. This approach works for any prevention study with relative risk data.

Question 5

Two studies examine the same exposure-disease relationship. Study A reports RR = 2.0 with a risk difference of 10%. Study B reports RR = 2.0 with a risk difference of 2%. What explains this apparent contradiction?

  1. The studies examined populations with different baseline disease risks (correct answer)
  2. One study made a calculation error since RR and risk difference must be proportional
  3. The studies used different exposure definitions leading to measurement bias
  4. Study A had a larger sample size providing more precise estimates
  5. The studies followed participants for different time periods affecting risk accumulation
Explanation: When you encounter questions comparing relative risk (RR) and risk difference across studies, remember that these measures capture different aspects of association and are influenced differently by baseline disease risk. The key insight is that relative risk and risk difference have a mathematical relationship that depends on baseline risk. If RR = 2.0, then the exposed group has twice the risk of the unexposed group. However, the absolute difference between these risks depends entirely on the baseline risk in the unexposed population. For Study A: If baseline risk = 10%, then exposed risk = 20%, giving RR = 20%/10% = 2.0 and risk difference = 20% - 10% = 10%. For Study B: If baseline risk = 2%, then exposed risk = 4%, giving RR = 4%/2% = 2.0 and risk difference = 4% - 2% = 2%. Both studies show the same relative effect (doubling of risk), but different absolute effects due to different baseline risks. Answer A correctly identifies that populations with different baseline disease risks explain this pattern. Answer B is wrong because RR and risk difference are not proportional - they have a multiplicative, not additive, relationship. Answer C is incorrect because different exposure definitions would likely change the RR estimates themselves, not just the risk differences. Answer D is wrong because sample size affects precision (confidence intervals), not the relationship between effect measures. Remember: relative risk tells you about the strength of association, while risk difference tells you about public health impact. Both depend on baseline risk, but in different ways.

Question 6

A safety analysis reveals that a medical device has a 0.3% complication rate compared to 0.1% for the standard procedure. The relative risk is 3.0. A hospital performs 10,000 procedures annually. If they switch to the standard procedure, how many complications would be prevented per year?

  1. 20 complications prevented annually (correct answer)
  2. 30 complications prevented annually
  3. 10 complications prevented annually
  4. 300 complications prevented annually
  5. 100 complications prevented annually
Explanation: When you encounter questions about risk differences and prevention calculations, you're working with absolute risk reduction - the actual difference in event rates between two interventions. To find how many complications would be prevented, you need to calculate the absolute difference in complication rates and apply it to the hospital's volume. The medical device has a 0.3% complication rate while the standard procedure has a 0.1% rate. The absolute risk reduction is 0.3% - 0.1% = 0.2%. With 10,000 procedures annually, switching to the standard procedure would prevent: 0.002×10,000=200.002 \times 10,000 = 20 complications per year. Let's examine why the other answers are incorrect. Answer B (30 complications) might result from mistakenly using the medical device's complication rate (0.3% × 10,000 = 30) rather than the risk difference. Answer C (10 complications) could come from using only the standard procedure's rate (0.1% × 10,000 = 10) instead of the difference between rates. Answer D (300 complications) represents a decimal error - perhaps calculating 0.3% as 0.03 instead of 0.003, leading to 0.03 × 10,000 = 300. The relative risk of 3.0 confirms our calculation is reasonable (0.3% ÷ 0.1% = 3.0) but isn't directly needed for this prevention calculation. Study tip: Always distinguish between relative measures (like relative risk) and absolute measures (like risk differences). For prevention calculations, focus on the absolute difference in rates, not the relative comparison between groups.

Question 7

A cohort study of 5,000 healthcare workers finds that proper hand hygiene reduces healthcare-associated infection transmission to patients (RR = 0.4). The baseline transmission rate is 6 infections per 100 healthcare workers per month. What is the prevented fraction among the exposed (vaccine efficacy equivalent)?

  1. 60% of infections are prevented by proper hand hygiene (correct answer)
  2. 40% of infections are prevented by proper hand hygiene
  3. 2.4% of infections are prevented by proper hand hygiene
  4. 3.6% of infections are prevented by proper hand hygiene
  5. 6% of infections are prevented by proper hand hygiene
Explanation: When you encounter questions about prevented fraction (also called vaccine efficacy or attributable efficacy), you're measuring how much disease exposure to a protective factor prevents. This is a fundamental concept in evaluating preventive interventions. The prevented fraction among the exposed uses the formula: Prevented Fraction=RRunexposed−RRexposedRRunexposed=1−RR1=1−RR\text{Prevented Fraction} = \frac{\text{RR}_{\text{unexposed}} - \text{RR}_{\text{exposed}}}{\text{RR}_{\text{unexposed}}} = \frac{1 - \text{RR}}{1} = 1 - \text{RR} Since the relative risk (RR) compares exposed to unexposed groups, and proper hand hygiene has RR = 0.4, this means healthcare workers with proper hygiene have 40% the infection risk of those without proper hygiene. The prevented fraction = 1 - 0.4 = 0.6 = 60%. This tells us that proper hand hygiene prevents 60% of the infections that would otherwise occur. Answer A correctly states that 60% of infections are prevented by proper hand hygiene. Answer B confuses the RR value (0.4 or 40%) with the prevented fraction—this is the residual risk, not what's prevented. Answers C and D incorrectly try to incorporate the baseline rate (6 infections per 100 workers), but prevented fraction is a relative measure independent of baseline incidence rates. Remember: prevented fraction always equals (1 - RR) when you have the relative risk. Don't let baseline rates distract you—this measure focuses purely on the proportional reduction in risk among those with the protective exposure.

Question 8

A public health intervention reduces childhood obesity from 18% to 12% in the target population. Health officials want to expand this program to a neighboring region with a current childhood obesity rate of 24%. Assuming the same relative effectiveness, what would be the expected obesity rate after intervention in the new region?

  1. 16% obesity rate in the new region (correct answer)
  2. 12% obesity rate in the new region
  3. 18% obesity rate in the new region
  4. 20% obesity rate in the new region
  5. 14% obesity rate in the new region
Explanation: When evaluating intervention effectiveness across different populations, you need to distinguish between absolute and relative effectiveness. This question tests whether you understand how to apply relative effectiveness consistently. The intervention reduced obesity from 18% to 12% in the original population. To find the relative effectiveness, calculate the relative risk reduction: the intervention retained 12%18%=23\frac{12\%}{18\%} = \frac{2}{3} of the original rate, meaning it reduced the rate by one-third relative to the baseline. Applying this same relative effectiveness to the new region with 24% baseline obesity: 24%×23=16%24\% \times \frac{2}{3} = 16\%. The answer is A) 16% obesity rate. Now for the incorrect options: B) 12% assumes the intervention achieves the same absolute final rate regardless of starting point, which ignores biological and social factors that make interventions more challenging in higher-risk populations. C) 18% incorrectly applies the original baseline rate as the final outcome. D) 20% might result from incorrectly calculating the absolute reduction (18% - 12% = 6%) and subtracting it from 24%, giving 18%, but this isn't even listed correctly and misunderstands relative versus absolute effectiveness. Remember this pattern: when interventions are described as having "the same relative effectiveness," multiply the new baseline by the same proportional change, not the same absolute change. Public health interventions typically show relative rather than absolute consistency across populations because underlying risk factors scale proportionally.

Question 9

A systematic review finds that exercise reduces cardiovascular disease risk (RR = 0.75). In a sedentary population with 8% 10-year cardiovascular disease risk, a community program achieves 60% exercise adoption. What is the overall population risk reduction achieved?

  1. 1.2 percentage points population risk reduction (correct answer)
  2. 2.0 percentage points population risk reduction
  3. 4.8 percentage points population risk reduction
  4. 6.0 percentage points population risk reduction
  5. 25% population risk reduction
Explanation: When you encounter questions about population-level interventions, you need to account for both the intervention's effectiveness and its actual uptake rate in the population. Here's how to calculate the population risk reduction step by step. First, determine the risk for each group after the intervention. Those who exercise (60% of population) have their risk reduced by the relative risk: 8%×0.75=6%8\% \times 0.75 = 6\%. Those who don't exercise (40% of population) maintain the original 8% risk. Next, calculate the new overall population risk using weighted averages: (0.60×6%)+(0.40×8%)=3.6%+3.2%=6.8%(0.60 \times 6\%) + (0.40 \times 8\%) = 3.6\% + 3.2\% = 6.8\% The population risk reduction is: 8%−6.8%=1.28\% - 6.8\% = 1.2 percentage points. Let's examine why the other answers are wrong. Answer B (2.0 percentage points) might result from incorrectly calculating the risk reduction as 8%×(1−0.75)×0.60=1.2%8\% \times (1-0.75) \times 0.60 = 1.2\%, then somehow doubling it. Answer C (4.8 percentage points) comes from multiplying the baseline risk by the adoption rate without properly accounting for the relative risk: 8%×0.60=4.8%8\% \times 0.60 = 4.8\%. Answer D (6.0 percentage points) represents the maximum possible reduction if 100% of the population adopted exercise: 8%×0.75=6%8\% \times 0.75 = 6\% absolute risk for exercisers, giving 8%−6%=2%8\% - 6\% = 2\% per person, but this ignores the 60% adoption rate. Remember: Population-level impact always equals individual benefit × intervention coverage. Don't forget to weight by actual participation rates, not theoretical maximums.

Question 10

A retrospective cohort study examines occupational exposure to asbestos and lung cancer risk over 30 years. Workers with high exposure have a lung cancer incidence of 45 per 1,000 workers, while those with low exposure have an incidence of 15 per 1,000 workers. What percentage of lung cancer cases among highly exposed workers is attributable to the excess exposure?

  1. 67% of cases are attributable to excess exposure (correct answer)
  2. 33% of cases are attributable to excess exposure
  3. 30% of cases are attributable to excess exposure
  4. 75% of cases are attributable to excess exposure
  5. 50% of cases are attributable to excess exposure
Explanation: When you encounter questions about exposure and disease risk, you're dealing with attributable risk concepts that help quantify how much disease can be blamed on a specific exposure. The key here is calculating the attributable risk percent (AR%) among the exposed group. This tells you what percentage of disease cases in the exposed population is due to the excess exposure beyond baseline risk. The formula is: AR%=Riskexposed−RiskunexposedRiskexposed×100AR\% = \frac{Risk_{exposed} - Risk_{unexposed}}{Risk_{exposed}} \times 100 Let's calculate: The highly exposed workers have 45 cases per 1,000, while low-exposure workers have 15 per 1,000. So: AR%=45−1545×100=3045×100=67%AR\% = \frac{45 - 15}{45} \times 100 = \frac{30}{45} \times 100 = 67\% This means 67% of lung cancer cases among highly exposed workers can be attributed to their excess asbestos exposure. Looking at the wrong answers: B (33%) represents a common error where students calculate the unexposed risk as a percentage of exposed risk (15/45 = 33%). C (30%) is the absolute risk difference (45-15 = 30) but not converted to a percentage of the exposed group. D (75%) might result from incorrectly using 40 instead of 45 in the denominator. Study tip: Always remember that attributable risk percent asks "of all cases in the exposed group, what fraction is due to the exposure?" The denominator is always the risk in the exposed group, and you're finding what proportion of that risk is excess beyond baseline.

Question 11

A randomized trial compares two pain medications. Drug A reduces pain in 70% of patients while Drug B reduces pain in 84% of patients. What is the relative risk of pain reduction for Drug B compared to Drug A?

  1. 1.2 (correct answer)
  2. 0.83
  3. 14 percentage points higher
  4. 20% more effective
  5. 1.14
Explanation: When you encounter questions about comparing treatment effectiveness between groups, you're typically being asked to calculate a relative risk, which compares the probability of an outcome in one group to another. Relative risk is calculated as the risk in the exposed group divided by the risk in the reference group. Here, you want to compare Drug B's effectiveness to Drug A's effectiveness: Relative Risk=Risk in Drug B groupRisk in Drug A group=0.840.70=1.2\text{Relative Risk} = \frac{\text{Risk in Drug B group}}{\text{Risk in Drug A group}} = \frac{0.84}{0.70} = 1.2 This means Drug B is 1.2 times as effective as Drug A, or 20% more effective than Drug A. Let's examine why the other options are incorrect. Option B (0.83) would be the relative risk if you incorrectly divided Drug A's effectiveness by Drug B's effectiveness (0.70/0.84), which gives you the wrong comparison direction. Option C (14 percentage points higher) describes the absolute risk difference (84% - 70% = 14%), not relative risk. While this is a correct calculation, it's not what the question asks for. Option D (20% more effective) describes the relative improvement correctly in words, but the question specifically asks for the relative risk value, not a descriptive interpretation. Remember that relative risk is always a ratio, typically expressed as a decimal. Values above 1.0 indicate the numerator group has higher risk (or in this case, better outcomes), while values below 1.0 indicate lower risk. Always pay attention to which direction the comparison should go based on the question wording.

Question 12

A clinical trial tests a new antiviral drug for treating influenza. The drug reduces symptom duration from an average of 7 days to 4.2 days, representing a 40% reduction. However, when examining the proportion of patients who recover within 5 days, the drug increases this from 30% to 65%. What is the relative risk of 5-day recovery with the new drug?

  1. 2.17 (correct answer)
  2. 1.40
  3. 0.60
  4. 35 percentage points improvement
  5. 2.35
Explanation: When you encounter questions about treatment effects and recovery rates, you're dealing with relative risk calculations. Relative risk compares the probability of an outcome occurring in the treatment group versus the control group. To calculate relative risk, you divide the risk (probability) in the treatment group by the risk in the control group. Here, the "risk" we're measuring is actually the positive outcome of recovering within 5 days. With the new drug, 65% of patients recover within 5 days, compared to 30% with standard treatment. Relative risk = Risk in treatment groupRisk in control group=0.650.30=2.17\frac{\text{Risk in treatment group}}{\text{Risk in control group}} = \frac{0.65}{0.30} = 2.17 This means patients are 2.17 times more likely to recover within 5 days when taking the new drug. Looking at the wrong answers: B) 1.40 represents the 40% reduction in symptom duration mentioned in the question stem, but that's not what we're calculating here. C) 0.60 would be the relative risk if you incorrectly flipped the fraction (30%/50%), suggesting the drug was harmful rather than beneficial. D) 35 percentage points improvement is the absolute risk difference (65% - 30%), not the relative risk. Remember that relative risk greater than 1 indicates increased likelihood of the outcome with treatment, while values less than 1 suggest decreased likelihood. Always pay attention to which specific outcome the question is asking about - here it's 5-day recovery, not overall symptom duration.

Question 13

A researcher finds that exposure to chemical Y increases cancer risk (RR = 2.5). The background cancer incidence in unexposed individuals is 8 per 1,000 over 10 years. What is the attributable risk among the exposed population?

  1. 12 per 1,000 over 10 years (correct answer)
  2. 20 per 1,000 over 10 years
  3. 8 per 1,000 over 10 years
  4. 2.5 per 1,000 over 10 years
  5. 28 per 1,000 over 10 years
Explanation: This question tests your understanding of attributable risk, a key epidemiological measure that quantifies the additional disease burden directly caused by an exposure. When you see relative risk (RR) and background incidence together, you're likely being asked to calculate either attributable risk or population attributable risk. To find attributable risk among the exposed, you need to determine how much additional cancer risk is caused by chemical Y exposure. Start with the formula: Attributable Risk = Incidence in exposed - Incidence in unexposed. First, calculate the incidence in exposed individuals. Since RR = 2.5, the exposed group has 2.5 times the cancer rate of the unexposed group: 2.5×8=202.5 \times 8 = 20 per 1,000 over 10 years. Now subtract the background rate: 20−8=1220 - 8 = 12 per 1,000 over 10 years. This means chemical Y causes an additional 12 cancer cases per 1,000 exposed individuals. Answer A (12 per 1,000) correctly represents this additional risk. Answer B (20 per 1,000) is the total incidence in exposed individuals, not the attributable risk. Answer C (8 per 1,000) is simply the background incidence rate. Answer D (2.5 per 1,000) confuses the relative risk value with an incidence rate. Remember: attributable risk always equals (RR - 1) × background incidence. Here, that's (2.5−1)×8=12(2.5 - 1) \times 8 = 12. This formula can save you time on exam questions involving attributable risk calculations.

Question 14

A pharmaceutical company reports that their new medication reduces heart attack risk by 50% compared to standard care (RR = 0.5). The baseline heart attack rate in the control group was 2% over 5 years. What is the absolute risk reduction (risk difference) provided by this medication?

  1. 1 percentage point reduction (correct answer)
  2. 50% risk reduction
  3. 1.5 percentage point reduction
  4. 0.5 percentage point reduction
  5. 2 percentage point reduction
Explanation: When you encounter questions about treatment effects, it's crucial to distinguish between relative measures (like relative risk) and absolute measures (like risk difference). Both tell important but different stories about a treatment's impact. To find the absolute risk reduction, you need to calculate the actual difference in event rates between groups. Start with the control group's baseline risk of 2% over 5 years. With a relative risk of 0.5, the treatment group's risk becomes: 2%×0.5=1%2\% \times 0.5 = 1\%. The absolute risk reduction is simply the difference: 2%−1%=1 percentage point2\% - 1\% = 1\text{ percentage point}. Answer A (1 percentage point reduction) correctly captures this calculation. This means that for every 100 patients treated for 5 years, one additional heart attack would be prevented compared to standard care. Answer B (50% risk reduction) confuses relative and absolute measures. While the relative risk reduction is indeed 50%, this isn't the absolute risk reduction the question asks for. Answer C (1.5 percentage point reduction) appears to stem from incorrectly calculating the treatment group's risk, possibly as 0.5% instead of 1%. Answer D (0.5 percentage point reduction) likely comes from misunderstanding how to apply the relative risk, perhaps subtracting 0.5 directly from the baseline risk. Remember this key distinction: relative risk tells you the proportional change, while absolute risk reduction tells you the actual difference in event rates. Both are clinically important, but they answer different questions about treatment benefit.

Question 15

An epidemiologist calculates that smoking increases lung cancer risk 15-fold in a particular population. The lung cancer incidence among non-smokers is 2 per 10,000 person-years. For a city with 200,000 smokers, what is the annual excess burden of lung cancer attributable to smoking?

  1. 560 excess lung cancer cases annually (correct answer)
  2. 600 excess lung cancer cases annually
  3. 40 excess lung cancer cases annually
  4. 580 excess lung cancer cases annually
  5. 300 excess lung cancer cases annually
Explanation: When you encounter questions about excess disease burden, you're calculating how many additional cases occur due to a specific exposure compared to what would happen without that exposure. To find the excess burden, you need three key pieces: the baseline risk in unexposed people, the relative risk from exposure, and the size of the exposed population. Here, non-smokers have 2 lung cancer cases per 10,000 person-years, smoking increases risk 15-fold, and there are 200,000 smokers. First, calculate the absolute risk in smokers: 2×15=302 \times 15 = 30 cases per 10,000 person-years. Next, find the excess risk (difference between smoker and non-smoker rates): 30−2=2830 - 2 = 28 excess cases per 10,000 person-years. Finally, apply this to the population: 2810,000×200,000=560\frac{28}{10,000} \times 200,000 = 560 excess cases annually. Choice A (560 cases) correctly applies this three-step calculation. Choice B (600 cases) likely represents the mistake of multiplying the total smoker risk (30 per 10,000) by 200,000, forgetting to subtract the baseline risk that would occur anyway. Choice C (40 cases) appears to use the baseline non-smoker rate instead of the excess rate. Choice D (580 cases) is close to the correct answer but represents a calculation error, possibly in the arithmetic steps. Remember: excess burden always requires subtracting the background rate from the exposed group's rate. You're calculating additional cases that wouldn't have occurred without the exposure, not the total cases in exposed individuals.

Question 16

In a randomized controlled trial, 150 patients receive a new drug and 150 receive placebo. The adverse event rate is 20% in the treatment group and 8% in the placebo group. What is the risk difference (attributable risk)?

  1. 0.12 or 12 percentage points (correct answer)
  2. 2.5 times higher risk
  3. 0.08 or 8 percentage points
  4. 0.20 or 20 percentage points
  5. 0.28 or 28 percentage points
Explanation: When you encounter questions about adverse events in clinical trials, you're typically being asked to calculate measures of risk association. Risk difference (also called attributable risk) is one of the most fundamental measures - it simply tells you how much additional risk is attributable to the treatment itself. Risk difference is calculated as the absolute difference between the risk in the exposed group and the risk in the unexposed group. Here, the treatment group has a 20% adverse event rate and the placebo group has an 8% rate. So: Risk difference = 20% - 8% = 12% (or 0.12). This means the new drug is associated with 12 additional adverse events per 100 patients treated. Let's examine why the other options are incorrect. Option B (2.5 times higher risk) represents the relative risk ratio (20%/8% = 2.5), which tells you the treatment group has 2.5 times the risk of the placebo group - this is a different measure entirely. Option C (8 percentage points) gives you only the placebo group's baseline risk, ignoring the treatment effect. Option D (20 percentage points) is just the treatment group's risk without accounting for what would have happened anyway (the baseline risk). The correct answer is A: 0.12 or 12 percentage points. Study tip: Remember that risk difference answers "How many extra cases per 100 people?" while relative risk answers "How many times higher is the risk?" Always subtract the unexposed group rate from the exposed group rate for risk difference calculations.

Question 17

A research team conducted a prospective cohort study to evaluate the effectiveness of a new diabetes prevention program. They followed 2,000 high-risk individuals for 3 years. Half received the intervention (diet counseling and exercise program) while the other half received standard care. The results are shown in the table below.

Based on the table above, what is the number needed to treat (NNT) for the diabetes prevention program?

  1. 20 individuals need treatment to prevent one case of diabetes (correct answer)
  2. 25 individuals need treatment to prevent one case of diabetes
  3. 50 individuals need treatment to prevent one case of diabetes
  4. 40 individuals need treatment to prevent one case of diabetes
  5. 10 individuals need treatment to prevent one case of diabetes
Explanation: From the table: Intervention group risk = 80/1000 = 0.08 (8%). Control group risk = 130/1000 = 0.13 (13%). Risk difference = 0.13 - 0.08 = 0.05 (5%). NNT = 1/risk difference = 1/0.05 = 20. Choice B uses incorrect risk calculation. Choice C represents 1/control group risk. Choice D represents 1/intervention group risk. Choice E represents half the correct calculation.

Question 18

A pharmaceutical company conducted a large randomized controlled trial to test a new cholesterol medication. The study enrolled 8,000 participants with elevated cholesterol levels and followed them for 4 years. Participants were randomly assigned to receive either the new medication or a placebo. The primary outcome was the development of major cardiovascular events (heart attack, stroke, or cardiovascular death).

Based on the results shown in the table, what is the relative risk of major cardiovascular events for the new medication compared to placebo?

  1. 0.67 (correct answer)
  2. 1.5
  3. 0.75
  4. 1.33
  5. 0.8
Explanation: From the table: New medication group risk = 200/4000 = 0.05 (5%). Placebo group risk = 300/4000 = 0.075 (7.5%). Relative risk = 0.05/0.075 = 0.67. Choice B is the inverse (1/0.67). Choice C uses incorrect calculation. Choice D represents placebo risk relative to treatment. Choice E uses wrong ratio calculation.

Question 19

In a case-control study, researchers found that 60% of cases with myocardial infarction had a history of smoking compared to 30% of controls. If the study had been designed as a cohort study with the same underlying population and smoking prevalence of 35%, what additional information would be needed to calculate the relative risk?

  1. The odds ratio from the case-control study and total sample size of cases and controls
  2. The incidence rate of myocardial infarction in the source population and follow-up time (correct answer)
  3. The sensitivity and specificity of smoking history assessment in both study designs
  4. The prevalence of myocardial infarction and the confidence intervals for exposure proportions
Explanation: To calculate relative risk, we need the incidence rates in exposed (smokers) and unexposed (non-smokers) groups. While the case-control study tells us about exposure distribution among cases and controls, it doesn't directly provide incidence rates. We need the disease incidence rate in the population and follow-up time to convert the exposure odds to actual risks in a hypothetical cohort. Choice A is incorrect because OR alone cannot be converted to RR without knowing disease incidence. Choice C is incorrect as it addresses measurement error, not the fundamental design difference. Choice D is incorrect because prevalence doesn't provide the temporal risk information needed for RR calculation.

Question 20

A study reports that the relative risk of developing diabetes for individuals with BMI ≥30 compared to BMI <25 is 3.2 (95% CI: 2.1-4.9). If the baseline incidence of diabetes in the BMI <25 group is 2 per 1,000 person-years, and you want to calculate the number needed to treat (NNT) for a weight loss intervention that reduces BMI from ≥30 to <25, what intermediate calculation is required?

  1. Convert the relative risk to odds ratio using the baseline incidence rate and study duration
  2. Calculate the absolute risk difference between BMI ≥30 and BMI <25 groups using baseline incidence (correct answer)
  3. Determine the population attributable risk fraction using the prevalence of obesity in the study population
  4. Estimate the hazard ratio from the relative risk using the assumption of proportional hazards over time
Explanation: To calculate NNT, we need the absolute risk difference (ARD). Given: RR = 3.2, baseline risk (BMI <25) = 2/1,000 person-years. Risk in BMI ≥30 group = 3.2 × 2 = 6.4/1,000 person-years. ARD = 6.4 - 2 = 4.4/1,000 person-years. NNT = 1/ARD = 1,000/4.4 ≈ 227. Choice A is incorrect because we don't need OR for NNT calculation. Choice C is incorrect because population attributable risk fraction is not needed for individual NNT. Choice D is incorrect because hazard ratio conversion is unnecessary and doesn't help with NNT calculation.